In 100 participants (148 eyes) with dry AMD, multiwavelength photobiomodulation vs sham met the primary visual acuity endpoint at 21 months (+6.2 letters; P=0.0036); progression to geographic atrophy at 24 months was 6.8% vs 24.0%.
RCTn = 100
Jaffe et al. LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS)